HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION Govt Leadership Needed to Promote Industry Reorganization, Strengthen Competitiveness: Former JPMA President Aoki
August 17, 2015
-
BUSINESS ASCO Immunotherapy Roundup - 7: Patient Group Hails Dawn of New Cancer Treatment Era
August 14, 2015
-
ORGANIZATION Govt’s Policy Blueprint Will Lead to Soaring R&D Costs, More Early-Stage Projects: JPMA Drug Evaluation Chief
August 14, 2015
-
BUSINESS Kyowa Kirin Looks to Derive 40% of Sales Overseas by 2020, Split from Holdings Firm Won’t Happen: Pres.
August 13, 2015
-
ORGANIZATION Drug Pricing Tomorrow: Full Interview with JPA Executive Director Abe
August 13, 2015
-
BUSINESS ASCO Immunotherapy Roundup - 6: CAR T-Cell Therapy Another Hot Field in Immuno-Oncology
August 12, 2015
-
TRENDS Japan Drug Makers See Rising Overseas Sales Ratios in April-June
August 11, 2015
-
ORGANIZATION Drug Pricing Tomorrow: FPMAJ’s Kamoya Says Innovation Premium Meant to Head Off Future Drug Lags
August 10, 2015
-
BUSINESS ASCO Immunotherapy Roundup - 5: Merck & Co. Discovers New Biomarkers for Keytruda
August 7, 2015
-
BUSINESS 80% Generic Target “Completely Unexpected,” and Makes Stable Growth in Japan Market Difficult: Pfizer Pres.
August 6, 2015
-
ORGANIZATION JPMA IP Committee Chair Predicts “Minimum Standard” for Data Protection Period for Drugs
August 5, 2015
-
BUSINESS Kyowa Kirin to Draw Up 5-Year Midterm Plan Focusing on Development of Global Products: President Hanai
August 4, 2015
-
ORGANIZATION “All-Japan” System Needed to Contend with Top Global Drug Makers: JPMA R&D Head
August 3, 2015
-
BUSINESS Wholesalers Must Ponder Use of Reps for New Business: Mediceo CEO
July 31, 2015
-
BUSINESS AbbVie Pres. Says Japan Attracting Foreign Investments, Confident in Hep C Drug
July 31, 2015
-
BUSINESS ASCO Immunotherapy Roundup - 4: Merck KGaA Trailing Rivals with ADCC-Inducing Avelumab
July 30, 2015
-
BUSINESS Delving into Securities Filings - 2: Drug Maker Employees Decrease 0.9% in 5 Years
July 30, 2015
-
BUSINESS New AbbVie Japan Chief Says Generics Making Room for Innovation
July 29, 2015
-
BUSINESS Delving into Securities Filings - 1: Average Salary of 25 Makers Up 4.9% in 5 Years, Generic Players Close in on Top-Tier Firms
July 29, 2015
-
ORGANIZATION Drug Pricing Tomorrow: JPA’s Abe Eyes Longer-Term Trial for Key Pricing Premium
July 28, 2015
ページ
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
In a recent conversation with James Feliciano, former president of AbbVie Japan, we delved into the intricacies of leadership in the Japanese pharmaceutical industry. Feliciano, a seasoned industry veteran, shared valuable insights into his experiences, challenges, and successes.Navigating the Abbott…